Trial
NCT01475162
Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
—
Condition
Acute Graft Versus Host Disease
Intervention
Tocilizumab
Why stopped
The DSMB felt the risks of the study now outweighed the potential benefits.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-17